Evaluation of beta-cell secretory capacity using glucagon-like peptide 1

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Evaluation of beta-cell secretory capacity using glucagon-like peptide 1. / Vilsbøll, Tina; Nielsen, Mette Toft; Krarup, T; Madsbad, S; Dinesen, Birthe Irene; Holst, Jens Møller.

I: Diabetes Care, Bind 23, Nr. 6, 01.06.2000, s. 807-12.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Vilsbøll, T, Nielsen, MT, Krarup, T, Madsbad, S, Dinesen, BI & Holst, JM 2000, 'Evaluation of beta-cell secretory capacity using glucagon-like peptide 1', Diabetes Care, bind 23, nr. 6, s. 807-12.

APA

Vilsbøll, T., Nielsen, M. T., Krarup, T., Madsbad, S., Dinesen, B. I., & Holst, J. M. (2000). Evaluation of beta-cell secretory capacity using glucagon-like peptide 1. Diabetes Care, 23(6), 807-12.

Vancouver

Vilsbøll T, Nielsen MT, Krarup T, Madsbad S, Dinesen BI, Holst JM. Evaluation of beta-cell secretory capacity using glucagon-like peptide 1. Diabetes Care. 2000 jun. 1;23(6):807-12.

Author

Vilsbøll, Tina ; Nielsen, Mette Toft ; Krarup, T ; Madsbad, S ; Dinesen, Birthe Irene ; Holst, Jens Møller. / Evaluation of beta-cell secretory capacity using glucagon-like peptide 1. I: Diabetes Care. 2000 ; Bind 23, Nr. 6. s. 807-12.

Bibtex

@article{44bf44c12d314981b2c5f670b599f0ea,
title = "Evaluation of beta-cell secretory capacity using glucagon-like peptide 1",
abstract = "Beta-cell secretory capacity is often evaluated with a glucagon test or a meal test. However, glucagon-like peptide 1 (GLP-1) is the most insulinotropic hormone known, and the effect is preserved in type 2 diabetic patients.",
author = "Tina Vilsb{\o}ll and Nielsen, {Mette Toft} and T Krarup and S Madsbad and Dinesen, {Birthe Irene} and Holst, {Jens M{\o}ller}",
year = "2000",
month = jun,
day = "1",
language = "English",
volume = "23",
pages = "807--12",
journal = "Diabetes Care",
issn = "0149-5992",
publisher = "American Diabetes Association",
number = "6",

}

RIS

TY - JOUR

T1 - Evaluation of beta-cell secretory capacity using glucagon-like peptide 1

AU - Vilsbøll, Tina

AU - Nielsen, Mette Toft

AU - Krarup, T

AU - Madsbad, S

AU - Dinesen, Birthe Irene

AU - Holst, Jens Møller

PY - 2000/6/1

Y1 - 2000/6/1

N2 - Beta-cell secretory capacity is often evaluated with a glucagon test or a meal test. However, glucagon-like peptide 1 (GLP-1) is the most insulinotropic hormone known, and the effect is preserved in type 2 diabetic patients.

AB - Beta-cell secretory capacity is often evaluated with a glucagon test or a meal test. However, glucagon-like peptide 1 (GLP-1) is the most insulinotropic hormone known, and the effect is preserved in type 2 diabetic patients.

M3 - Journal article

VL - 23

SP - 807

EP - 812

JO - Diabetes Care

JF - Diabetes Care

SN - 0149-5992

IS - 6

ER -

ID: 34069926